Abstract LB-252: Efficacy and safety results of Betalutin (177Lu-DOTA-HH1) in a phase III study of patients with non-hodgkin B-cell lymphoma (NHL) von Kolstad, Arne, Madsbu, Ulf, Beasley, Matthew, Bayne, Michael, Stokke, Caroline, Bach-Gansmo, Tore, Lndalen, Ayca Muftuler, Holtedahl, Jon Erik, Revheim, Mona Elisabeth, Bruland, yvind, Dahle, Jostein, Curtis, Laurie Baylor, stengen, se, Turner, Simon, Bolstad, Nils, Larsen, Roy H, Spetalen, Signe, Erlanson, Martin, Rud, Stine Nygaard, Holte, Harald

Volltext